TOP >>Main Part 2012 >>2-2 >>Obstetrics and Gynecology
Obstetrics and Gynecology |
Director KIKKAWA, Fumitaka (Professor) 4W · 4E |
Treatment of ovarian cancer providing relief based on the outstanding number of patients in Japan |
In addition to the main fields of obstetrics and gynecology (gynecologic oncology, perinatal medicine, and reproductive medicine), we provide medical care for all fields of obstetrics and gynecology. |
15 academic personnel including professors and 13 consulting doctors provide inpatient medical care in the general outpatient clinic, specialized outpatient clinics, 4W ward (gynecology), 4E ward (perinatal medicine), and center for maternal-neonatal care (MFICU and reproductive technique). Two on-duty doctors are present for childbirth and emergency surgery.
Malignant tumor (e.g. cervical cancer, endometrial cancer, ovarian cancer), trophoblastic disease (e.g. hydatidiform mole, choriocarcinoma), high-risk pregnancy (e.g. pregnancy-induced hypertension syndrome, complicated pregnancy, placenta previa, fetal abnormality), infertility, gynecologic disease for which endoscopic surgery is indicated (endometriosis and uterine myoma), and climacteric disturbance.
We have treated an outstanding number of patients with ovarian cancer in Japan. We also make efforts for fertility preservation treatment of early-stage malignant tumor in younger patients. In addition, we have broad experience in cases of trophoblastic disease, fetal abnormality, placenta previa accreta, endoscopic surgery, and in vitro fertilization / microinsemination.
Cervical cancer: 41, endometrial cancer: 43, ovarian cancer: 50, trophoblastic disease: 13, childbirth: 492 (cesarean section: 193), maternal transport: 31, fetal congenital anomaly: 53, endoscopic surgery: 93, in vitro fertilization: 100 egg collection cycles (2010).
As a core hospital in the Chubu District, we provide the most advanced medical care in each of the following specialized outpatient clinics: tumor, high-risk pregnant women, reproductive medicine, endoscopic surgery, and menopause. We also provide second opinions.
We perform radical trachelectomy, which is a fertility preservation surgery, for early invasive cervical cancer. We develop ALA-PDT (photodynamic therapy) and immunotherapy targeting the novel carcinoembryonic antigen and aim at their clinical application. We have introduced robot-assisted laparoscopic surgery for hysterectomy.